# Cisplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer

> **NCT00066222** · PHASE2 · COMPLETED · sponsor: **Radiation Therapy Oncology Group** · enrollment: 72 (actual)

## Conditions studied

- Lung Cancer

## Interventions

- **DRUG:** Cisplatin
- **DRUG:** Etoposide
- **RADIATION:** Radiation therapy

## Key facts

- **NCT ID:** NCT00066222
- **Lead sponsor:** Radiation Therapy Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-06
- **Primary completion:** 2012-05
- **Final completion:** 2013-11
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2017-12-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00066222

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00066222, "Cisplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00066222. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*